Riskpilot← Back to searchSign inGet full accessAprobia AB
ABDissolvedOrg 5567846315Manufacture of other food products n.e.c. · NACE 1089Est. 20090 employees
Revenue 2023
SEK 0
EBITDA margin
—
-5% vs 2022
Equity ratio
82.4%
Financial strength
Net profit 2023
SEK -20K
-5% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -20K | -5% |
| Net profit | SEK -20K | -5% |
| Total assets | SEK 74K | -16% |
| Equity | SEK 61K | +20% |
| Employees | 0 | — |
Legal name
Aprobia AB
Org number
5567846315
Legal form
Aktiebolag
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
1 juli 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska producera och marknadsföra produkter för att stärka magfunktioner och immunförsvar samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 122 | 148 | 47 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 78 | 90 | 41 | −19 | −20 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 78 | 90 | 41 | −19 | −20 |
| Net financials | — | — | −608 | — | — |
| Profit before tax | 15 | 68 | −241 | −19 | −20 |
| Tax | −0 | −14 | −13 | −0 | −0 |
| Net profit | 15 | 54 | −254 | −19 | −20 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 167 | 276 | 126 | 88 | 74 |
| Equity | 145 | 199 | 70 | 51 | 61 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 | 55 | 56 | 37 | 13 |
| Total debt | 21 | 55 | 56 | 37 | 13 |
EBITDA margin
-2000000.0%
This company
15.8%
Market median
-12658328% vs market
20192023
Equity ratio
82.4%
This company
38.2%
Market median
+116% vs market
20192023
Return on equity
-32.8%
This company
18.4%
Market median
-278% vs market
20192023
Net profit margin
-2000000.0%
This company
8.1%
Market median
-24691458% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
JR Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
PA | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2021 – 2024 | |
| Deputy Board Member | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
de Faire Medical TopCo AB
Aprobia AB Board members of Aprobia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Robin De Faire | Chief Executive Officer | 0 companies |
| Patrik Andreas Löfving | Audit | 0 companies |
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Per Mikael Bergman | Board of Directors | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Urban Falkmarken | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |